Stock Analysis of Cassava Sciences Inc (SAVA) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code SAVA
Close 22.03
Change -0.420 / 1.87 %
Volume 597823
Vol Change 171262 / 40.15 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthMild Bullish
Growth Index Poor Growth Stock
Value Index Poor Value Stock
Profitability Index Poor Profitability Stock
Stability Index Excellent Stability


Fundamental View of Cassava Sciences Inc
PE (TTM)

-18.51

Very Poor
Price / Book

6.20

Very Poor
Price / Sales

398.35

Very Poor
Piotroski F Score

3.0

Not Good
Market Cap

1056.92 M

Enterprise Value

935779 K

ROA (TTM)

-28.22

Very Poor
ROE (TTM)

-33.49

Very Poor
Net Margin (TTM)

-2152.26

Very Poor
Revenue

100.00 %

0
Net Profit

27.50 %

-97217.00 K
Debt to Equity

0

Excellent
Altman Z Score

39.92

Excellent
Quick Ratio

0

Poor
Cash Ratio

8.53

Excellent


Highs/Lows of Cassava Sciences Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week21.715 1.45 % 0.513 % 22.899921.1531-May-2428-May-24
Two Week23.12 4.71 % 0.486 % 23.5921.1520-May-2428-May-24
One Month22.15 0.542 % 4.80 % 24.1219.9315-May-2407-May-24
Three Month22.98 4.13 % 3.56 % 26.675718.1811-Apr-2411-Mar-24
Six Months20.83 5.76 % 15.54 % 32.118.1812-Dec-2311-Mar-24
One year22.71 2.99 % 26.26 % 32.112.320212-Dec-2313-Oct-23
Two year30.6 28.01 % 27.72 % 45.4312.320214-Dec-2213-Oct-23
Five year1.1 1902.73 % 91.77 % 51.591.0322-Sep-2229-Aug-19
Ten year34.65 36.42 % 174.36 % 146.160.7629-Jul-2126-Dec-18


Technical View of Cassava Sciences Inc
RSI

51.03

Neutral
MACD

0.072

Bearish
ADX

10.85

Neutral
Super Trend

24.10

Mild Bearish
Williams %R

-54.12

Neutral
CCI

31.92

Neutral


EMA 5

21.96

Strong Bullish
EMA 15

21.93

Mild Bullish
EMA 50

21.88

Neutral
EMA 100

22.03

Whipsaw
SMA 100

22.48

Whipsaw
SMA 200

21.49

Whipsaw
SMA 5 / 20

21.83 / 21.87

Bearish
SMA 15 / 50

21.95 / 21.62

Bullish
SMA 50 / 200

21.62 / 21.49

Mild Bullish




Charts of Cassava Sciences Inc


Returns of Cassava Sciences Inc with Peers
Period / StockSAVAELVNVECTMDXG
1 Week1.45%-5.72%-0.119%-7.74%
1 Mth-0.542%29.79%1.08%16.07%
3 Mth-4.13%41.33%84.96%-12.38%
6mth5.76%100.44%89.54%-7.98%
1 Year-2.99%23.33%186.08%22.01%
2 Year-28.01%16.58%66.83%82.86%
5 Years1902.73%--57.14%
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Cassava Sciences Inc with Peers
Ratio / StockSAVAELVNVECTMDXG
PE-18.51-11.71-8.194558.51
P/B6.203.346.192921.58
ROA-28.22-26.89-62.8329.27
ROE-33.49-28.51-75.5680.48
Debt To Equity00.00140.04890.348
Revenue0
100.00 % 		0
% 		27341.00 K
% 		309020 K
15.37 %
Net Income-97217.00 K
27.50 % 		-71584.00 K
4910.75 % 		-93735.00 K
7.73 % 		4337.00 K
111.79 %


Technicals of Cassava Sciences Inc with Peers
Technical / StockSAVAELVNVECTMDXG-
ADX10.8521.3554.7122.75
CMF-0.1270.140-0.055-0.120
MFI65.6233.3777.8946.17
RSI51.0352.6967.1043.73
MACD Abv SignalFalseFalseFalseFalse
Price Above 50 MATrueTrueTrueFalse-
Price Above 200 MATrueTrueTrueFalse-


About : Cassava Sciences Inc

Address : 6801 N. Capital of Texas Highway, Austin, TX, United States, 78731
Tel : 512 501 2444
URL : https://www.cassavasciences.com
Code : SAVA, ISIN : US14817C1071, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 14_Jul_2000
Employee Count : 29

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.


Note : All Data Generated at the End of Trading Hours (EOD Data)